The open-label, single-arm study enrolled 23 adult patients undergoing their first kidney transplant from either living or ...

A pan-cancer analysis of 2,930 patients across 11 tumor types found that ALK mutation was associated with significantly ...

This Research Topic is one volume within the series "The Future of Checkpoint Immunotherapy: New Roads Ahead". Please see the ...

Cancer cells can disarm the immune system not just by hiding from it, but by actively reprogramming nearby immune cells into ...

Researchers at MD Anderson have identified RNase H2 as a key survival mechanism in triple-negative breast cancer, helping ...

Study identifies citraconate as a metabolic regulator that reverses T cell exhaustion, suppresses lipid-driven toxicity and ...

New study reveals ALK mutation enhances tumor immunogenicity and predicts favorable outcomes in immune checkpoint blockade ...